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Abstract
Background: Intravenous adenosine in conjunction with myocardial perfusion imaging is
commonly used for the detection of coronary artery disease and risk assessment. We have
previously shown that patients with ischemic changes on the 12-lead electrocardiogram (ECG)
in response to adenosine but with normal perfusion pattern have a benign outcome on short-
intermediate follow-up. The long-term outcome of these patients is unknown.
Methods: Patients with ischemic ECG response (≥ 1 mm ST depression) to adenosine
infusion but with normal perfusion on single-photon emission computed tomography (SPECT)
imaging in the absence of a history of myocardial infarction or coronary revascularization
were followed up for mortality, myocardial infarctions, and coronary revascularization.
Results: The cohort consisted of 73 patients (81% women) who were followed up for mortality
for a mean of 61 ± 15 months. There were 10 deaths, and the cause of death was determined to be
non-cardiac in half of those. Follow-up for the other endpoints was complete for 21 ± 10 months
during which no patient had myocardial infarction and seven underwent coronary
revascularization.
Conclusions: Patients with ischemic ECG response to intravenous adenosine administration
and normal perfusion on SPECT are at low risk of cardiovascular events. The ST segment
response to adenosine in this setting is likely related to non-ischemic mechanisms. (Cardiol J
2009; 16, 2: 121–126)




Myocardial perfusion imaging using single-pho-
ton emission computed tomography (SPECT) is
widely used both for the detection of coronary ar-
tery disease and for risk assessment [1]. In the
United States, more than one third of all SPECT
imaging is done using coronary vasodilators, most
commonly with intravenous adenosine [2]. The risk
of death or myocardial infarction in patients with
normal images after adenosine has been shown to
be around 1% per year [3–5], slightly higher than
the risk in patients with normal exercise perfusion
images [6–8], which is probably related to the higher
cardiovascular risk profile of this patient population.
Most patients with ST segment depression noted
on the electrocardiogram (ECG) after adenosine
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infusion have reversible perfusion defects [9].
Although it has been suggested that patients with
ischemic ECG changes during adenosine infusion
but with normal perfusion on SPECT images are at
increased risk [10, 11], we have previously demon-
strated that this population has a benign outcome
on short to intermediate follow-up [12]. We report
here on the largest cohort in the literature of such
patients, and show that on long-term follow-up the-
se patients continue to be at low risk.
Methods
We studied patients with ischemic ST segment
response to adenosine but with normal perfusion on
SPECT imaging (Fig. 1). We previously reported the
short-term outcome in a subset of these patients [12].
Patients were included if they underwent adenosi-
ne SPECT at the University of Alabama at Birming-
ham Nuclear Cardiology Laboratory between May
2001 and July 2003. Exclusion criteria included prior
myocardial infarction, prior coronary revasculariza-
tion, or the presence of left bundle branch block, non-
sinus rhythm, or paced rhythm in resting ECG. Pa-
tients who were taking digitalis or had ST/T wave
abnormalities that preclude the interpretation of the
stress ECG response were also excluded.
Adenosine was administered intravenously at
a standard infusion rate of 140 µg/kg/min for five
minutes. No exercise was done during the infusion.
Technetium-99m sestamibi or tetrofosmin was in-
jected at 3 min into the adenosine infusion. The
SPECT gated images were acquired with an ellip-
tical 180° acquisition using a dual head detector
(45° RAO to 45° LAO) and 8 frames per R-R cycle
as previously described [12]. The perfusion images
were interpreted visually without attenuation cor-
rection, and quantitative analysis (polar images) was
used to supplement the visual analysis. The left
ventricular ejection fraction was measured by the
method of Germano et al. [13].
A standard 12-lead ECG was performed on the
same day and prior to the adenosine infusion. ECG
was monitored continuously during infusion and
a 12-lead ECG was printed every minute. An ische-
mic response was defined as 1 mm or greater flat
or down-sloping ST segment depression, or a 1.5 mm
or greater up-sloping ST segment depression in two
or more contiguous leads at 80 ms from the J point
using the TP segment as the isoelectric reference
in accordance with accepted guidelines [14]. The
changes had to normalize after the termination of
the infusion. The physician reading the ECGs was
blinded to the perfusion on SPECT imaging.
Follow-up was performed for all patients by
a single physician. Outcomes of interest included
cardiac death, non-fatal myocardial infarction, per-
cutaneous coronary intervention, coronary artery
bypass grafting, or death from any cause. The out-
comes were determined by reviewing the medical
records or by telephone interviews with the pa-
tients, or if the patient was deceased, with a first
degree relative. Mortality was established by con-
ducting a search of the US Social Security Death
Master File for the entire cohort on 15 February
2008.
All statistical analyses were performed using
the SPSS® version 11.5 for Windows® (SPSS® Inc.,
Chicago, IL). Categorical data were presented as
frequencies and continuous variables were presen-
ted as means ± standard deviations. The survival
curve was constructed using the product-limit me-
thod (Kaplan-Meier).
The institutional review board for human re-
search at the University of Alabama at Birmingham
approved the study. There were no complications
from this study.
Results
During the specified period, 73 patients satis-
fied the study protocol and therefore constituted the
study cohort. Baseline characteristics of these pa-
tients are summarized in Table 1. The left ventri-
cular ejection fraction by gated SPECT was 70 ±
± 11% (range 47–94).
The patients were followed up for mortality for
a mean of 61 ± 15 (range 7–79) months. There were
10 deaths. The mean age of the patients at death
was 71 ± 14 years. These deaths occurred at
a median of 30 (range 7–60) months from the ade-
nosine SPECT studies. The cause of death was do-
cumented to be non-cardiac in 5 of these; 4 patients
died with metastatic cancers and the 5th patient was
96 years old with end-stage dementia receiving end-
-of-life hospice care. The cause of death in the other
5 patients was not available to us. The Kaplan-
-Meier curve for survival of the cohort is shown in
Figure 2. Follow-up for myocardial infarction and
coronary revascularization was complete for 21 ±
± 10 (range 1–38) months. During follow-up no pa-
tient had myocardial infarction. Seven patients un-
derwent coronary revascularization; 4 had percuta-
neous coronary interventions (for single vessel co-
ronary artery disease), and 3 had coronary artery
bypass grafting. The coronary revascularizations
were performed at a median of 2 (range 0–24) mon-
ths after the adenosine SPECT. During a mean
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Figure 1. A stress test performed on a 48-year-old woman with renal disease who underwent screening for coronary
artery disease; A. A 12-lead electrocardiogram at rest shows sinus rhythm with no ST depression; B. During
adenosine infusion her electrocardiogram demonstrates 1–2 mm down-slopping ST depression in V3–V5 as well as
in leads II and aVF; C. The adenosine (panels 1, 3, 5 and 7) and rest (remaining panels) SPECT MIBI images
demonstrated normal perfusion pattern; the left ventricular ejection fraction was normal (not shown). Over the next
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follow-up of 5 years, the annual rate of all-cause
mortality was 2.7% and cardiovascular mortality
was 1.3% or less as the cause of death was unknown
in half of the patients. On the other hand, during
the mean follow-up of almost 2 years, the annual
rates of myocardial infarction and coronary revascu-
larization were 0% and 5.5%, respectively.
Discussion
The aim of this study was to determine the
long-term prognosis of patients with ischemic ECG
response to intravenous adenosine administration
and normal perfusion on SPECT images. We report
that in a cohort of 73 patients with these characte-
ristics, the annual cardiovascular mortality during
a mean follow-up of 5 years was less than 1.3%.
Similarly, the annual rates of myocardial infarc-
tions and coronary revascularization during a shor-
ter follow-up of almost 2 years were 0% and 5.5%,
respectively. This study, therefore, re-enforces
our previous conclusion that this population is at
low risk [12].
Most patients with ST segment depression
during adenosine infusion have reversible defects
and only a minority demonstrate normal perfusion
on imaging [15, 16]. The ST segment depression is
thought to represent myocardial ischemia seconda-
ry to coronary steal. For this to occur in the setting
of normal perfusion images after adenosine admi-
nistration, a ‘perfectly balanced’ decrease in perfu-
sion in the coronary artery tree due to a ‘perfectly
balanced’ symmetric distribution of stenotic coro-
nary artery lesions has to occur. This mechanism
is hypothetical, but it is widely feared in the car-
diovascular community and has been notoriously
labelled as ‘balanced ischemia’. The high positive
predictive value of ST response during adenosine
infusion [9, 17–19] has raised the concern that ba-
lanced ischemia might be the reason behind the
normal images, and that such patients should be
considered at high-risk [10, 11].  It is well accepted
now that ST segment depression during exercise
stress testing does not add prognostic data to per-
fusion images [20]. In 2003 Abbott et al. [10] repor-
ted on 66 patients with ischemic ECG changes and
normal perfusion after adenosine stress. During
a follow-up period of 29 ± 12 months, 2 patients had
cardiac death, 5 patients sustained non-fatal my-
ocardial infarctions, and 9 patients underwent sub-
sequent coronary revascularization. At the same
time Klodas et al. [11] reported on 49 patients that
they followed for 28 ± 20 months; in this popula-
tion, the corresponding numbers are 2, 4, and
8 patients. When we examined a similar population
of 65 patients from our institution with no prior
myocardial infarction or coronary revascularization
that we followed for 24 ± 8 months, we observed
no cardiac death or myocardial infarction, while
6 patients underwent coronary revascularization [12].
Chow et al. [21] also reported on 72 patients with
dipyridamole-induced ischemic ECG changes but
normal perfusion using positron emission tomogra-
phy. At a mean follow-up of 27 ± 13 months there
were no cardiac deaths, 1 patient had non-fatal
myocardial infarction, and 2 patients underwent
coronary revascularization. Given that the conclu-
sions from these studies were different, it is obvious
that the rates of events do not match those seen in
Table 1. Baseline characteristics.
Variable (n = 73)
Age (years) 65 ± 12
Women 60 (81%)
Diabetes mellitus 20 (27%)
Hypertension 54 (74%)
Beta-blocker therapy 18 (25%)
Calcium channel blocker therapy 25 (34%)
Nitrate therapy 6 (8%)
Prior myocardial infarction 0
Prior coronary revascularization 0
Prior stress myocardial 12 (16%)
perfusion imaging
Prior coronary angiography 1 (1%)
Figure 2. Kaplan-Meier curve showing the survival (from
all-cause mortality) of patients with ST segment depres-
sion in response to adenosine but with normal perfusion.
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patients with 3-vessel or left main coronary artery
disease [22, 23] and therefore do not support the
original hypothesis of balanced ischemia causing
ECG changes, which was missed on perfusion ima-
ging. This conclusion is supported by the benign
outcome of these patients on long-term follow-up
as shown here. Although false negative SPECT
imaging with vasodilators does occur, and it should
be suspected in the right clinical setting, the pre-
sence of ischemic ECG changes during stress te-
sting does not seem to add to the prognostic power
of this test. It should be noted that in the large stu-
dy by Hachamovitch et al. [24], ischemic ECG chan-
ges in response to adenosine did not surface as
a predictor of outcome in the overall risk predic-
tion score after adjustments for other variables.
This ischemic ST response to adenosine, de-
spite a normal perfusion pattern on imaging, occurs
mostly in women (80–90%), as evidenced by our
study and others [10–12, 21]. A similar higher pre-
ponderance of false positive ECG changes during
exercise stress test in women [25, 26] suggests that
there might be an intrinsic gender-related differen-
ce in the ST response to exercise as well as to va-
sodilation. This effect has been attributed to oestro-
gen [27–29]. To explore this, Henzlova et al. [30]
examined the ECG response to exercise in a cohort
of women with normal perfusion on SPECT imaging
and found that exogenous oestrogen therapy incre-
ased the ST segment response to exercise. Seve-
ral investigators have similarly suggested that
oestrogen might have a digoxin-like effect on the
ST segment [31–33]. It is therefore reasonable to
suggest that the ST segment response to adenosi-
ne that is encountered in the setting of normal per-
fusion on SPECT imaging occurs probably through
a non-ischemic mechanism and is more prevalent
in women. The benign long-term outcome of our
population lends further support to this hypothesis.
Conclusions
In conclusion, patients with ischemic ECG re-
sponse to intravenous adenosine administration and
normal perfusion on SPECT are at low risk of car-
diovascular events, even after long-term follow-up.
The ST segment response to adenosine, in this
setting, is predominantly in females and is likely
related to non-ischemic mechanisms.
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